Literature DB >> 2467354

Phenotypic and functional features of CD5+ B lymphocytes in rheumatoid arthritis.

C Plater-Zyberk1, R N Maini.   

Abstract

Using flow cytometry B lymphocytes expressing CD5 were increased in the blood of 15 out of 31 patients with rheumatoid arthritis (RA). In contrast to the monoclonal CD5+ B lymphocytes in patients with B-chronic lymphocytic leukaemia, CD5+ B cells from RA patients and neonatal cord blood are polyclonal as demonstrated by kappa/lambda expression. These B cells co-express mu and delta heavy chains and are CD19, CD20, CD21 positive. Purified CD5+ and CD5- B cells appeared of similar size and granularity as judged by light scatter values. Staphylococcus aureus C stimulated cord blood B cells showed loss of CD5 antigen following activation and production of similar amounts of IgM-rheumatoid factor (RF). EBV stimulation of purified RA B subsets lead to greater production of IgM-RF by CD5+ B cells than by CD5-B cells suggesting an enrichment of precursor cells in this fraction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2467354     DOI: 10.3109/03009748809096744

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


  3 in total

1.  Coordinate expansion of 'fetal type' lymphocytes (TCR gamma delta+T and CD5+B) in rheumatoid arthritis and primary Sjögren's syndrome.

Authors:  F Brennan; C Plater-Zyberk; R N Maini; M Feldmann
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

2.  Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients.

Authors:  Jeff Hosry; Roberto N Miranda; Felipe Samaniego; Minas P Economides; Harrys A Torres
Journal:  Int J Cancer       Date:  2017-11-03       Impact factor: 7.396

3.  Sequence analysis of immunoglobulin heavy-chain variable region genes from the synovium of a rheumatoid arthritis patient shows little evidence of mutation but diverse CDR3.

Authors:  C M Brown; K J Fitzgerald; S P Moyes; R A Mageed; D G Williams; R N Maini
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.